Therapeutic amides

Details Therapeutic amides Therapeutic amides

2008-10-29

2010-06-01

Qazi, Sabiha (Department: 1612)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S313000, C514S314000, C546S153000, C546S157000, C546S180000, C546S183000

Reexamination Certificate

active

07728007

ABSTRACT:
The invention provides compounds of the formula:wherein X, Y, and Z are as defined in the specification. The compounds are effective anti-tumor agents. The invention also provides pharmaceutical compositions comprising a compound of the above formula or a salt thereof, intermediates useful for preparing a compound of the above formula, and therapeutic methods comprising administering a compound of the above formula or a salt thereof to a mammal in need thereof.

REFERENCES:
patent: 4269493 (1981-05-01), Suzuki et al.
patent: 4559157 (1985-12-01), Smith et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4629493 (1986-12-01), Ura et al.
patent: 4710507 (1987-12-01), Campbell et al.
patent: 4760066 (1988-07-01), Busse et al.
patent: 4812163 (1989-03-01), Hiramatsu et al.
patent: 4820508 (1989-04-01), Wortzman
patent: 4938949 (1990-07-01), Borch et al.
patent: 4992478 (1991-02-01), Geria
patent: 5250690 (1993-10-01), Turner et al.
patent: 5364831 (1994-11-01), Ura et al.
patent: 5696119 (1997-12-01), Behrens et al.
patent: 6103913 (2000-08-01), Hay et al.
patent: 6133457 (2000-10-01), Patel
patent: 6160006 (2000-12-01), Edwards et al.
patent: 6197728 (2001-03-01), Ura et al.
patent: 6238644 (2001-05-01), Rillema
patent: 6252064 (2001-06-01), Martinelli et al.
patent: 6352991 (2002-03-01), Zemlicka et al.
patent: 6586461 (2003-07-01), Gibbs
patent: 6680311 (2004-01-01), Al-Awar et al.
patent: 6703415 (2004-03-01), Mobashery et al.
patent: 6747021 (2004-06-01), Corbett et al.
patent: 6790841 (2004-09-01), Zemlicka et al.
patent: 6867219 (2005-03-01), Horwitz et al.
patent: 7109341 (2006-09-01), Horwitz et al.
patent: 7585863 (2009-09-01), Horwitz et al.
patent: 2006/0293333 (2006-12-01), Horwitz et al.
“U.S. Appl. No. 10/613,914, Non-Final Office Action mailed Oct. 28, 2005”, 8 pgs.
“U.S. Appl. No. 10/613,914, Notice of Allowance mailed May 15, 2006”, 4 pgs.
“U.S. Appl. No. 10/613,914, Response filed Feb. 10, 2006 to Non-Final Office Action mailed Oct. 28, 2005”, 9 pgs.
“U.S. Appl. No. 10/613,914, Restriction Requirement mailed Feb. 2, 2005”, 7 pgs.
“U.S. Appl. No. 11/469,205 Non-Final Office Action mailed Sep. 25, 2008”, OARN, 2 Pgs.
“U.S. Appl. No. 11/469,205, Preliminary Amendment filed Aug. 31, 2006”, 10 pgs.
“Australian Application Serial No. 2003249704, Examiner's Report mailed Aug. 13, 2008”, 2 pgs.
“Chinese Application Serial No. 03815880.9, First Office Action mailed Jun. 30, 2006”, 10 pgs.
“Chinese Application Serial No. 03815880.9, Office Action mailed Apr. 11, 2008”, 10 pgs.
“Indian Application Serial No. 1569/KOLNP/2004-F, First Examination Report mailed Feb. 22, 2006”, 3 pgs.
“Indonesian Application Serial No. W-00200500292, Office Action mailed Mar. 24, 2008”, 4 pgs.
“Intenational Application Serial No. PCT/US03/21062, International Preliminary Examination Report mailed Nov. 16, 2004”, 8 pgs.
“Intenational Application Serial No. PCT/US03/21062, International Search Report mailed Nov. 3, 2003”, 8 pgs.
“Intenational Application Serial No. PCT/US03/21062, Written Opinion mailed Mar. 11, 2003”, 5 pgs.
“International Application Serial No. 200500095, Office Action mailed Mar. 10, 2006”, 4 pgs.
“International Application Serial No. 535887, Examination Report mailed Mar. 16, 2005”, 4 pgs.
“International Search Report , Application No. PCT/US 03/21062, Date mailed Nov. 3, 2003”, 8 Pages.
Balasubramanian, B. N, et al., “Recent Developments in Cancer Cytotoxics”,Annual Reports in Medicinal Chemistry, (1998), 151-159.
Bertino, J. R, et al., “Principles of Cancer Therapy”,Oncology XIV, 21st Edition, vol. 1, (2000), 1049-1062.
Corbett, T. H, et al., “Preclinical Antitumor Efficacy of Analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy) phenoxy] propionate”,Investigational New Drugs, 16(2), (1998), 129-139.
Draetta, G., et al., “Section V Topics in Biology”,Annual Reports in Medicinal Chemistry, 31, (1996), 241-246.
Hazeldine, S. T., et al., “Design, Synthesis and Biological Evaluation of Analogues of the Antitumor Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy} propionic Acid(XK169)”,J. Med. Chem., 44(11), (Apr. 28, 2001), 1758-1776.
Hazeldine, S. T., et al., “II. Synthesis and Biological Evaluation of Some Bioisosteres and Congeners of the Antitumor Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic Acid (XK469)”,J. Med. Chem., 45, (2002), 3130-3137.
Tietze, L. F, et al., “ImprovedSynthesisof (E)-3-Alkoxy- and (E)-3-Phenoxyacryloyl Chlorides”, Synthesis, (Nov. 1993), 1079-1080.
“U.S. Appl. No. 11/469,205, Response filed Nov. 25, 2008 to Non-Final Office Action mailed Sep. 25, 2008”, 28 pgs.
“U.S. Appl. No. 11/469,205, Final Office Action mailed Mar. 3, 2009”, FOAR, 5 pgs.
“U.S. Appl. No. 11/469,205, Notice of Allowance mailed May 15, 2009”, 10 pgs.
“U.S. Appl. No. 11/469,205, Response filed Apr. 27, 2009 to Final Office Action mailed Mar. 3, 2009”, 9 pgs.
03763213.0, “European Application No. 03763213.0 , Office Action Mailed on Jul. 10, 2009”, 3.
03815880.9, “Chinese Application No. 03815880.9 Office Action Mailed Dec. 19, 2008”, 6 pgs.
“Canadian Application Serial No. 2491612, Office Action Received Nov. 25, 2009.”, 4 pgs.

Affiliated with

Also associated with

Rating

Therapeutic amides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic amides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4157309